Skip Navigation

European Heart Journal 1987 8(2):130-140;
Copyright © 1987 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by REMME, W. J.
Right arrow Articles by KRUYSSEN, H. A. C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by REMME, W. J.
Right arrow Articles by KRUYSSEN, H. A. C. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 The European Society of Cardiology

Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease

W. J. REMME*,, D.C.A. VAN HOOGENHUYZE*, X. H. KRAUSS*, A. HOFMAN{dagger}, C. J. STORM* and H. A. C. M. KRUYSSEN*

*Department of Cardiology, Zuiderziekenhuis Rotterdam, The Netherlands
{dagger}Department of Epidemiology, Erasmus University Rotterdam, The Netherlands

Received 18 February 1986; revised 29 July 1986; .

Address for correspondence W. J. Remme, M.D., Department of Cardiology, Zuiderziekenhuis, Groene Hilledijk 315, 3075 EA Rotterdam, The Netherlands.

Abstract

The acute coronary and systemic haemodynamic effects of intravenous bepridil were investigated in 27 patients with coronary artery disease; 13 (group 1) received 2 mg kg–1 and 14 (group 2) 4 mg kg–1 over 5 min. An immediate systemic and coronary vasodilation occurred in both groups during and immediately after the infusion. Changes were dose-related with a maximal decrease in left ventricular (LV) systolic pressure of 11% (group 1) and 18% (group 2), in mean aortic pressure of 11% (group 1) and 19% (group 2), and in coronary resistance of 23% (group 1) and 41% (group 2). Coronary flow increased by 17% (group 1) and 47% (group 2) (all changes significantly different from control (C) values and between groups). Cardiac output, measured immediately after bepridil, was unaltered, although in group 2 stroke volume index increased (14%) and systemic resistance decreased (16%), both P<0.05 vs C. In group 2, heart rate (HR) and contractility. initially increased (8% and 10%, respectively, P<0.05 vs C), secondary to the greater fall in afterload, followed by a significant reduction at 5 and 10 min after bepridil (9% and 10%, respectively), accompanied by a 36% increase in LV enddiastolic pressure (P<0.05 vs C). No such changes were observed in group 1, apart from a simultaneous decrease in HR (9%, P<0.05 vs C). Thus, in humans, a dose-related, biphasic haemodynamic pattern is observed with intravenous bepridil, consisting of an acute, short-lasting vasodilation, followed by late negative chronotropic and inotropic effects, which, with longterm bepridil administration, may be beneficial during myocardial ischaemia.

Key Words: Bepridil • calcium-blocking drug • coronary artery disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.